1. 665PNRF2 activation via PI3K/AKT/mTOR/RPS6 causes resistance to anti-HER2 agents among HER2 amplified gastric cancer. (23rd October 2018) Authors: Gambardella, V; Gimeno-Valiente, F; Tarazona, N; Fleitas Kanonnikoff, T; Tolosa, P; Belda Moscardò, M; Garcia-Mico, B; Huerta, M; Roselló, S; Roda, D; Cervantes, A; Castillo, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗